1-3 of 3
Hervé Tilly, M.D.
Close
Sort by
Journal Articles

Phase I Study of RO5072759 (GA101) in Relapsed/Refractory Chronic Lymphocytic Leukemia.

Franck Morschhauser, MD, PhD, Guillaume Cartron, MD, Thierry Lamy, MD, PhD, Noel-Jean Milpied, MD, PhD, Catherine Thieblemont, MD, PhD, Hervé Tilly, M.D., Martin Weisser, MD, Joe Birkett, Ph.D., Gilles Andre Salles, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 884.
https://doi.org/10.1182/blood.V114.22.884.884
Published: 2009
Journal Articles

Non Germinal-Center B Cell Like Diffuse Large B Cell Lymphoma Results From Repeated Activation of IgM B Cells That Resist Class-Switching.

Philippe Ruminy, Ph.D, Lucile Couronné, Fabrice Jardin, MD, PhD, Francoise Parmentier, Vincianne Rainville, Camille Mauger, Jean-Michel Picquenot, MD, Bernard Lenormand, MD, Marie Cornic, Philippe Bertrand, PhD, Hervé Tilly, M.D., Christian Bastard, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 318.
https://doi.org/10.1182/blood.V114.22.318.318
Published: 2009
Journal Articles

A Phase I/II Study of RO5072759 (GA101) in Patients with Relapsed/Refractory CD20 + Malignant Disease

Gilles Andre Salles, MD, PhD, Franck Morschhauser, M.D., Guillaume Cartron, M.D., Thierry Lamy, MD, PhD, Noel-Jean Milpied, M.D., PhD, Catherine Thieblemont, M.D., Hervé Tilly, M.D., Joe Birkett, Ph.D., Mike Burgess, M.D.
Journal: Blood
Blood (2008) 112 (11): 234.
https://doi.org/10.1182/blood.V112.11.234.234
Published: 2008